FAH and Tyrosinemia type 1: Next, Rossidis et al. [44] demonstrated the possibility of in utero base editing to rescue a neonatally lethal disease using a mouse model for hereditary tyrosinemia type 1 (HT1), a metabolic liver disease caused by a mutation in the fumarylacetoacetate hydrolase (Fah) gene.